- Home
- IQV vs BSBR Comparison
IQV vs BSBR Comparison
Compare IQV & BSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IQV
- BSBR
- Stock Information
- Founded
- IQV 1982
- BSBR 1985
- Country
- IQV United States
- BSBR Brazil
- Employees
- IQV N/A
- BSBR N/A
- Industry
- IQV Biotechnology: Commercial Physical & Biological Resarch
- BSBR Commercial Banks
- Sector
- IQV Health Care
- BSBR Finance
- Exchange
- IQV Nasdaq
- BSBR Nasdaq
- Market Cap
- IQV 35.7B
- BSBR 33.6B
- IPO Year
- IQV 2013
- BSBR 2009
- Fundamental
- Price
- IQV $197.47
- BSBR $4.20
- Analyst Decision
- IQV Strong Buy
- BSBR Buy
- Analyst Count
- IQV 17
- BSBR 1
- Target Price
- IQV $255.88
- BSBR $6.00
- AVG Volume (30 Days)
- IQV 1.2M
- BSBR 696.2K
- Earning Date
- IQV 02-12-2025
- BSBR 02-05-2025
- Dividend Yield
- IQV N/A
- BSBR 6.56%
- EPS Growth
- IQV 27.98
- BSBR 26.22
- EPS
- IQV 7.62
- BSBR 0.30
- Revenue
- IQV $15,315,000,000.00
- BSBR $8,670,618,732.00
- Revenue This Year
- IQV $3.67
- BSBR N/A
- Revenue Next Year
- IQV $4.53
- BSBR N/A
- P/E Ratio
- IQV $25.89
- BSBR $6.80
- Revenue Growth
- IQV 3.10
- BSBR 8.02
- 52 Week Low
- IQV $187.62
- BSBR $3.75
- 52 Week High
- IQV $261.73
- BSBR $6.12
- Technical
- Relative Strength Index (RSI)
- IQV 45.36
- BSBR 55.14
- Support Level
- IQV $194.06
- BSBR $3.94
- Resistance Level
- IQV $207.72
- BSBR $4.14
- Average True Range (ATR)
- IQV 4.74
- BSBR 0.10
- MACD
- IQV 0.12
- BSBR 0.05
- Stochastic Oscillator
- IQV 27.90
- BSBR 94.68
About IQV IQVIA Holdings Inc.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
About BSBR Banco Santander Brasil SA each representing one unit
Banco Santander (Brasil) SA is part of Santander Group, a Spanish bank. It operates across two segments; the Commercial Banking segment, catering to both individual and corporate client and the Global Wholesale Banking segment, which encompasses Investment Banking and Markets operations, including the Treasury and Equity Business Departments. The bank generates majority of its revenue from the Commercial Banking segment and has operations in Brazil and internationally.